ESC Professional Premium Access

RNA and gene therapy of vascular diseases

Event: ESC Congress 2022
Topic: Vascular Diseases
Session type: Moderated ePosters
Date: 29 August 2022
Time: 09:15 - 10:00

Congress Session

6 presentations in this session

Targeting RNA elongation in endothelial-to-mesenchymal transition

Speaker: Mr J. Hoba (Leipzig, DE)
Thumbnail

Overexpression of miR-210 ameliorates endothelial dysfunction in type 2 diabetic mice

Speaker: Doctor A. Collado (Stockholm, SE)
Thumbnail

Dicer prevents activation of the type I interferon pathway in lipid-loaded macrophages

Speaker: Mr N. Li (Munich, DE)
Thumbnail

Diagnostic ability of miR-19a and Let-7f along with platelet and leukocyte extracellular vesicles in acute ischemic stroke patients

Speaker: Mrs C. Eyileten (Warsaw, PL)
Thumbnail

An in vivo CRISPR base editing therapy to inactivate the ANGPTL3 gene: nomination of a development candidate for VERVE-201

Speaker: Doctor A. Khera (Cambridge, US)
Thumbnail

Targeted overexpression of regnase-1 in the aorta prevents aneurysm growth in a murine model of Marfan syndrome

Speaker: Miss M. Noormalal (Kiel, DE)
Thumbnail

6 speakers from this session

Mr Julian Hoba

University of Leipzig, Leipzig (Germany)
0 follower

Doctor Aida Collado

Karolinska Institute, Stockholm (Sweden)
0 follower

Mr Nan Li

Institute for Cardiovascular Prevention (IPEK-LMU), Munich (Germany)
0 follower

Mrs Ceren Eyileten

Medical University of Warsaw, Warsaw (Poland)
1 follower

Doctor Amit Khera

Verve Therapeutics, Cambridge (United States of America)
0 follower

Miss Marie Isabel Noormalal

University Medical Center of Schleswig-Holstein, Kiel (Germany)
0 follower

This platform is supported by

logo Novo Nordisk